Viridian Therapeutics, Inc. VRDN
- anti-TSHR antibody — Graves' Disease Preclinical
- VRDN-292 — Graves' Disease Preclinical
- VRDN-292 — Thyroid Eye Disease Preclinical
TSHR (2 companies · 5 programs)
Companies with an active program directed at TSHR.
Septerna, Inc. SEPN
- SEP-204 — Graves' Disease Preclinical
- SEP-204 — Thyroid Eye Disease Preclinical